Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulfafurazole diolamine |
Is a |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfafurazole acetyl |
Is a |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Accidental sulphafurazole poisoning |
Causative agent (attribute) |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Intentional sulphafurazole poisoning |
Causative agent (attribute) |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
intoxication par le sulfafurazole d'intention indéterminée |
Causative agent (attribute) |
False |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole adverse reaction |
Causative agent (attribute) |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Allergy to sulfisoxazole |
Causative agent (attribute) |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfisoxazole measurement |
Component |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Poisoning by sulfafurazole |
Causative agent (attribute) |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfafurazole 40 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfisoxazole 500mg/5 ml suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Product containing sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Product containing phenazopyridine and sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
2 |
Accidental sulphafurazole poisoning |
Causative agent (attribute) |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Intentional sulphafurazole poisoning |
Causative agent (attribute) |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Product containing sulfafurazole in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
|
Product containing sulfafurazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Allergy to sulfisoxazole |
Causative agent (attribute) |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole diolamine |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfafurazole acetyl |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Sulfafurazole |
Inferred relationship |
Some |
|
Sulfafurazole 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Product containing erythromycin and sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
2 |
Sulfafurazole-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Product containing only erythromycin and sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
2 |
Product containing only phenazopyridine and sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
2 |
Product containing only sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 40 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 40 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 100 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |
Sulfafurazole 100 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfafurazole |
Inferred relationship |
Some |
1 |